INTERNATIONAL PATENT: BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. FILES APPLICATION FOR "ANTI-TPBG/MUC1 ANTIBODIES AND USES THEREOF"

GENEVA, Sept. 8 -- BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (No.12 Baoshen South Street, Daxing Bio-Medicine Industry ParkDaxing District, Beijing 102600) filed a patent application (PCT/CN2025/079190) for "ANTI-TPBG/MUC1 ANTIBODIES AND USES THEREOF" on Feb 26, 2025. With publication no. WO/2025/180383, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XU, Yangyang (No.12 Baoshen South Street, Daxing Bio-Medicine Industry ParkDaxing District, Beijing 102600), ZHANG, Yifu (No.12 Baoshen South Street, Daxing Bio-Medicin...